Recall Enforment Report D-0435-2023
Drug Recall Enforcement Report Class II voluntary initiated by Sagent Pharmaceuticals Inc, originally initiated on 02-28-2023 for the product Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC carton: 25021-404-01 The product was recalled due to labeling: not elsewhere classified. The product was distributed nationwide and the recall is currently ongoing.
|NDC||Proprietary Name||Non-Proprietary Name||Dosage Form||Route Name||Company Name||Product Type|
|25021-404||Heparin Sodium||Heparin Sodium||Injection||Intravenous; Subcutaneous||Sagent Pharmaceuticals||Human Prescription Drug|